Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Cabozantinib for Patients with Advanced Renal Cell Carcinoma After Checkpoint Inhibitor Treatment

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany
  • Study of Dabrafenib and Drug Combination for Patients with Metastatic Non-Clear Cell Kidney Cancer

    Not recruiting

    2 1 1 1
    Denmark
  • Study on Atezolizumab and Cabozantinib for Patients with Advanced Renal Cell Carcinoma After Tumor Progression Post-Immune Checkpoint Inhibitor Treatment

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • Study on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Poland
  • Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia France Greece Italy Poland +2
  • Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Norway Slovakia Sweden
  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Denmark Finland France Germany Italy +3
  • Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Hungary The Netherlands Poland Spain
  • Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia Finland France Germany +7